# § 522.147   Atipamezole.

(a) *Specifications.* Each milliliter of solution contains 5.0 milligrams atipamezole hydrochloride.


(b) *Sponsors.* See Nos. 015914, 052483, 068504, and 069043 in § 510.600(c) of this chapter.


(c) *Conditions of use in dogs*—(1) *Amount.* Administer 3,750 mcg/m
2 intramuscularly for the reversal of intravenous dexmedetomidine hydrochloride or medetomidine hydrochloride and 5,000 mcg/m
2 intramuscularly for the reversal of intramuscular dexmedetomidine hydrochloride or medetomidine hydrochloride.




(2) *Indications for use.* For the reversal of the sedative and analgesic effects of dexmedetomidine hydrochloride and medetomidine hydrochloride.


(3) *Limitations.* Federal law restricts this drug to use by or on the order of a licensed veterinarian.



---

[N] [61 FR 48830, Sept. 17, 1996, as amended at 64 FR 71640, Dec. 22, 1999; 72 FR 264, Jan. 4, 2007; 84 FR 8973, Mar. 13, 2019; 88 FR 84700, Dec. 6, 2023; 89 FR 42357, May 15, 2024]




